nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—type 2 diabetes mellitus	0.33	1	CbGaD
Conivaptan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0528	0.152	CbGbCtD
Conivaptan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.047	0.136	CbGbCtD
Conivaptan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.043	0.124	CbGbCtD
Conivaptan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0376	0.109	CbGbCtD
Conivaptan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.034	0.0982	CbGbCtD
Conivaptan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0258	0.0744	CbGbCtD
Conivaptan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0247	0.0713	CbGbCtD
Conivaptan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0247	0.0713	CbGbCtD
Conivaptan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0234	0.0675	CbGbCtD
Conivaptan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0174	0.0503	CbGbCtD
Conivaptan—CYP3A4—Losartan—type 2 diabetes mellitus	0.0159	0.046	CbGbCtD
Conivaptan—Atorvastatin—DPP4—type 2 diabetes mellitus	0.00164	0.273	CrCbGaD
Conivaptan—Atorvastatin—HMGCR—type 2 diabetes mellitus	0.0014	0.232	CrCbGaD
Conivaptan—Deferasirox—CYP3A4—type 2 diabetes mellitus	0.000825	0.137	CrCbGaD
Conivaptan—Lomitapide—CYP3A4—type 2 diabetes mellitus	0.000652	0.108	CrCbGaD
Conivaptan—Atorvastatin—ABCC2—type 2 diabetes mellitus	0.000643	0.107	CrCbGaD
Conivaptan—Tolvaptan—CYP3A4—type 2 diabetes mellitus	0.000582	0.0965	CrCbGaD
Conivaptan—Headache—Tolazamide—type 2 diabetes mellitus	0.000431	0.00222	CcSEcCtD
Conivaptan—Erythema—Glyburide—type 2 diabetes mellitus	0.000431	0.00221	CcSEcCtD
Conivaptan—Malnutrition—Glyburide—type 2 diabetes mellitus	0.000431	0.00221	CcSEcCtD
Conivaptan—Confusional state—Glimepiride—type 2 diabetes mellitus	0.00043	0.00221	CcSEcCtD
Conivaptan—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000429	0.00221	CcSEcCtD
Conivaptan—Headache—Linagliptin—type 2 diabetes mellitus	0.000427	0.00219	CcSEcCtD
Conivaptan—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000425	0.00218	CcSEcCtD
Conivaptan—Infection—Sitagliptin—type 2 diabetes mellitus	0.000422	0.00217	CcSEcCtD
Conivaptan—Vomiting—Acarbose—type 2 diabetes mellitus	0.00042	0.00216	CcSEcCtD
Conivaptan—Cardiac failure—Ramipril—type 2 diabetes mellitus	0.000419	0.00215	CcSEcCtD
Conivaptan—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.000419	0.00215	CcSEcCtD
Conivaptan—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000417	0.00214	CcSEcCtD
Conivaptan—Infestation NOS—Metformin—type 2 diabetes mellitus	0.000414	0.00213	CcSEcCtD
Conivaptan—Infestation—Metformin—type 2 diabetes mellitus	0.000414	0.00213	CcSEcCtD
Conivaptan—Insomnia—Glipizide—type 2 diabetes mellitus	0.000413	0.00212	CcSEcCtD
Conivaptan—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000413	0.00212	CcSEcCtD
Conivaptan—Hyponatraemia—Ramipril—type 2 diabetes mellitus	0.000411	0.00211	CcSEcCtD
Conivaptan—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000409	0.0021	CcSEcCtD
Conivaptan—Nausea—Tolazamide—type 2 diabetes mellitus	0.000409	0.0021	CcSEcCtD
Conivaptan—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000407	0.00209	CcSEcCtD
Conivaptan—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000405	0.00208	CcSEcCtD
Conivaptan—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000403	0.00207	CcSEcCtD
Conivaptan—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.0004	0.00206	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000398	0.00205	CcSEcCtD
Conivaptan—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.000398	0.00205	CcSEcCtD
Conivaptan—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000398	0.00205	CcSEcCtD
Conivaptan—Anaemia—Glyburide—type 2 diabetes mellitus	0.000398	0.00205	CcSEcCtD
Conivaptan—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.000397	0.00204	CcSEcCtD
Conivaptan—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000396	0.00203	CcSEcCtD
Conivaptan—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.000395	0.00203	CcSEcCtD
Conivaptan—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000395	0.00203	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000394	0.00203	CcSEcCtD
Conivaptan—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000393	0.00202	CcSEcCtD
Conivaptan—Nausea—Acarbose—type 2 diabetes mellitus	0.000393	0.00202	CcSEcCtD
Conivaptan—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000392	0.00202	CcSEcCtD
Conivaptan—Pain—Glipizide—type 2 diabetes mellitus	0.00039	0.00201	CcSEcCtD
Conivaptan—Constipation—Glipizide—type 2 diabetes mellitus	0.00039	0.00201	CcSEcCtD
Conivaptan—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00039	0.00201	CcSEcCtD
Conivaptan—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000389	0.002	CcSEcCtD
Conivaptan—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000388	0.00199	CcSEcCtD
Conivaptan—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000387	0.00199	CcSEcCtD
Conivaptan—Erythema—Gliclazide—type 2 diabetes mellitus	0.000387	0.00199	CcSEcCtD
Conivaptan—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000385	0.00198	CcSEcCtD
Conivaptan—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000384	0.00197	CcSEcCtD
Conivaptan—Infection—Bromocriptine—type 2 diabetes mellitus	0.000382	0.00196	CcSEcCtD
Conivaptan—Pollakiuria—Losartan—type 2 diabetes mellitus	0.000381	0.00196	CcSEcCtD
Conivaptan—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.00038	0.00195	CcSEcCtD
Conivaptan—Nausea—Nateglinide—type 2 diabetes mellitus	0.000379	0.00195	CcSEcCtD
Conivaptan—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000379	0.00195	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000378	0.00194	CcSEcCtD
Conivaptan—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000378	0.00194	CcSEcCtD
Conivaptan—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000377	0.00194	CcSEcCtD
Conivaptan—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000376	0.00193	CcSEcCtD
Conivaptan—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000374	0.00192	CcSEcCtD
Conivaptan—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000373	0.00192	CcSEcCtD
Conivaptan—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000372	0.00191	CcSEcCtD
Conivaptan—Angiopathy—Valsartan—type 2 diabetes mellitus	0.00037	0.0019	CcSEcCtD
Conivaptan—Pneumonia—Losartan—type 2 diabetes mellitus	0.00037	0.0019	CcSEcCtD
Conivaptan—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000369	0.0019	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000368	0.00189	CcSEcCtD
Conivaptan—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000368	0.00189	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000367	0.00189	CcSEcCtD
Conivaptan—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000366	0.00188	CcSEcCtD
Conivaptan—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000363	0.00187	CcSEcCtD
Conivaptan—Pain—Sitagliptin—type 2 diabetes mellitus	0.000363	0.00187	CcSEcCtD
Conivaptan—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000363	0.00187	CcSEcCtD
Conivaptan—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000361	0.00185	CcSEcCtD
Conivaptan—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000359	0.00185	CcSEcCtD
Conivaptan—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000358	0.00184	CcSEcCtD
Conivaptan—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000357	0.00184	CcSEcCtD
Conivaptan—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000357	0.00184	CcSEcCtD
Conivaptan—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000357	0.00183	CcSEcCtD
Conivaptan—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000355	0.00183	CcSEcCtD
Conivaptan—Confusional state—Glyburide—type 2 diabetes mellitus	0.000354	0.00182	CcSEcCtD
Conivaptan—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000353	0.00182	CcSEcCtD
Conivaptan—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000351	0.0018	CcSEcCtD
Conivaptan—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000351	0.0018	CcSEcCtD
Conivaptan—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000351	0.0018	CcSEcCtD
Conivaptan—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00035	0.0018	CcSEcCtD
Conivaptan—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000348	0.00179	CcSEcCtD
Conivaptan—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000346	0.00178	CcSEcCtD
Conivaptan—Headache—Repaglinide—type 2 diabetes mellitus	0.000346	0.00178	CcSEcCtD
Conivaptan—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000345	0.00178	CcSEcCtD
Conivaptan—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000345	0.00177	CcSEcCtD
Conivaptan—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000345	0.00177	CcSEcCtD
Conivaptan—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000344	0.00177	CcSEcCtD
Conivaptan—Angiopathy—Metformin—type 2 diabetes mellitus	0.000337	0.00173	CcSEcCtD
Conivaptan—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000335	0.00172	CcSEcCtD
Conivaptan—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000334	0.00172	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000332	0.00171	CcSEcCtD
Conivaptan—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000329	0.00169	CcSEcCtD
Conivaptan—Hypotension—Glyburide—type 2 diabetes mellitus	0.000328	0.00169	CcSEcCtD
Conivaptan—Nausea—Repaglinide—type 2 diabetes mellitus	0.000328	0.00169	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000327	0.00168	CcSEcCtD
Conivaptan—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000327	0.00168	CcSEcCtD
Conivaptan—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000325	0.00167	CcSEcCtD
Conivaptan—Malnutrition—Metformin—type 2 diabetes mellitus	0.000324	0.00166	CcSEcCtD
Conivaptan—Erythema—Metformin—type 2 diabetes mellitus	0.000324	0.00166	CcSEcCtD
Conivaptan—Pruritus—Glipizide—type 2 diabetes mellitus	0.000323	0.00166	CcSEcCtD
Conivaptan—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000322	0.00165	CcSEcCtD
Conivaptan—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000318	0.00164	CcSEcCtD
Conivaptan—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000318	0.00164	CcSEcCtD
Conivaptan—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000317	0.00163	CcSEcCtD
Conivaptan—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000316	0.00162	CcSEcCtD
Conivaptan—Infection—Gliclazide—type 2 diabetes mellitus	0.000314	0.00161	CcSEcCtD
Conivaptan—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000312	0.00161	CcSEcCtD
Conivaptan—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00031	0.00159	CcSEcCtD
Conivaptan—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000309	0.00159	CcSEcCtD
Conivaptan—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000307	0.00158	CcSEcCtD
Conivaptan—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000306	0.00158	CcSEcCtD
Conivaptan—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000305	0.00157	CcSEcCtD
Conivaptan—Erythema—Irbesartan—type 2 diabetes mellitus	0.000305	0.00157	CcSEcCtD
Conivaptan—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000304	0.00156	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000303	0.00156	CcSEcCtD
Conivaptan—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000301	0.00155	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.0003	0.00154	CcSEcCtD
Conivaptan—Angiopathy—Losartan—type 2 diabetes mellitus	0.000299	0.00154	CcSEcCtD
Conivaptan—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000299	0.00154	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000297	0.00153	CcSEcCtD
Conivaptan—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000296	0.00152	CcSEcCtD
Conivaptan—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000295	0.00152	CcSEcCtD
Conivaptan—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000292	0.0015	CcSEcCtD
Conivaptan—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000292	0.0015	CcSEcCtD
Conivaptan—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000291	0.00149	CcSEcCtD
Conivaptan—Vomiting—Glipizide—type 2 diabetes mellitus	0.00029	0.00149	CcSEcCtD
Conivaptan—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00029	0.00149	CcSEcCtD
Conivaptan—Infection—Valsartan—type 2 diabetes mellitus	0.000288	0.00148	CcSEcCtD
Conivaptan—Erythema—Losartan—type 2 diabetes mellitus	0.000287	0.00148	CcSEcCtD
Conivaptan—Headache—Glipizide—type 2 diabetes mellitus	0.000286	0.00147	CcSEcCtD
Conivaptan—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000285	0.00147	CcSEcCtD
Conivaptan—Infection—Orlistat—type 2 diabetes mellitus	0.000285	0.00146	CcSEcCtD
Conivaptan—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000284	0.00146	CcSEcCtD
Conivaptan—Atorvastatin—CYP3A4—type 2 diabetes mellitus	0.000284	0.0471	CrCbGaD
Conivaptan—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000282	0.00145	CcSEcCtD
Conivaptan—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000282	0.00145	CcSEcCtD
Conivaptan—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000281	0.00144	CcSEcCtD
Conivaptan—Hypertension—Metformin—type 2 diabetes mellitus	0.000279	0.00144	CcSEcCtD
Conivaptan—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000279	0.00143	CcSEcCtD
Conivaptan—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000278	0.00143	CcSEcCtD
Conivaptan—Headache—Pioglitazone—type 2 diabetes mellitus	0.000274	0.00141	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000274	0.00141	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000272	0.0014	CcSEcCtD
Conivaptan—Nausea—Glipizide—type 2 diabetes mellitus	0.000271	0.00139	CcSEcCtD
Conivaptan—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000271	0.00139	CcSEcCtD
Conivaptan—Hypotension—Valsartan—type 2 diabetes mellitus	0.000271	0.00139	CcSEcCtD
Conivaptan—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00027	0.00139	CcSEcCtD
Conivaptan—Pain—Gliclazide—type 2 diabetes mellitus	0.00027	0.00139	CcSEcCtD
Conivaptan—Constipation—Gliclazide—type 2 diabetes mellitus	0.00027	0.00139	CcSEcCtD
Conivaptan—Headache—Glimepiride—type 2 diabetes mellitus	0.000267	0.00137	CcSEcCtD
Conivaptan—Headache—Sitagliptin—type 2 diabetes mellitus	0.000266	0.00137	CcSEcCtD
Conivaptan—Anaemia—Losartan—type 2 diabetes mellitus	0.000266	0.00136	CcSEcCtD
Conivaptan—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000264	0.00135	CcSEcCtD
Conivaptan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000263	0.00135	CcSEcCtD
Conivaptan—Infection—Metformin—type 2 diabetes mellitus	0.000262	0.00135	CcSEcCtD
Conivaptan—Insomnia—Valsartan—type 2 diabetes mellitus	0.000262	0.00135	CcSEcCtD
Conivaptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00026	0.00134	CcSEcCtD
Conivaptan—Insomnia—Orlistat—type 2 diabetes mellitus	0.000259	0.00133	CcSEcCtD
Conivaptan—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000259	0.00133	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000258	0.00133	CcSEcCtD
Conivaptan—Skin disorder—Metformin—type 2 diabetes mellitus	0.000256	0.00132	CcSEcCtD
Conivaptan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000255	0.00131	CcSEcCtD
Conivaptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000254	0.00131	CcSEcCtD
Conivaptan—Nausea—Glimepiride—type 2 diabetes mellitus	0.000253	0.0013	CcSEcCtD
Conivaptan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000252	0.0013	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00025	0.00129	CcSEcCtD
Conivaptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000249	0.00128	CcSEcCtD
Conivaptan—Pruritus—Glyburide—type 2 diabetes mellitus	0.000249	0.00128	CcSEcCtD
Conivaptan—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000248	0.00127	CcSEcCtD
Conivaptan—Constipation—Valsartan—type 2 diabetes mellitus	0.000248	0.00127	CcSEcCtD
Conivaptan—Infection—Irbesartan—type 2 diabetes mellitus	0.000248	0.00127	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000247	0.00127	CcSEcCtD
Conivaptan—Hypotension—Metformin—type 2 diabetes mellitus	0.000247	0.00127	CcSEcCtD
Conivaptan—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000246	0.00127	CcSEcCtD
Conivaptan—Erythema—Ramipril—type 2 diabetes mellitus	0.000246	0.00127	CcSEcCtD
Conivaptan—Pain—Orlistat—type 2 diabetes mellitus	0.000245	0.00126	CcSEcCtD
Conivaptan—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000244	0.00126	CcSEcCtD
Conivaptan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000244	0.00126	CcSEcCtD
Conivaptan—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000242	0.00124	CcSEcCtD
Conivaptan—Headache—Bromocriptine—type 2 diabetes mellitus	0.000241	0.00124	CcSEcCtD
Conivaptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00024	0.00124	CcSEcCtD
Conivaptan—Dry mouth—Losartan—type 2 diabetes mellitus	0.000239	0.00123	CcSEcCtD
Conivaptan—Confusional state—Losartan—type 2 diabetes mellitus	0.000236	0.00122	CcSEcCtD
Conivaptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000236	0.00121	CcSEcCtD
Conivaptan—Infection—Losartan—type 2 diabetes mellitus	0.000233	0.0012	CcSEcCtD
Conivaptan—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000233	0.0012	CcSEcCtD
Conivaptan—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00023	0.00118	CcSEcCtD
Conivaptan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00117	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000228	0.00117	CcSEcCtD
Conivaptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000226	0.00116	CcSEcCtD
Conivaptan—Constipation—Metformin—type 2 diabetes mellitus	0.000226	0.00116	CcSEcCtD
Conivaptan—Vomiting—Glyburide—type 2 diabetes mellitus	0.000223	0.00115	CcSEcCtD
Conivaptan—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000223	0.00115	CcSEcCtD
Conivaptan—Headache—Glyburide—type 2 diabetes mellitus	0.00022	0.00113	CcSEcCtD
Conivaptan—Hypotension—Losartan—type 2 diabetes mellitus	0.000219	0.00113	CcSEcCtD
Conivaptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000218	0.00112	CcSEcCtD
Conivaptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000216	0.00111	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000215	0.00111	CcSEcCtD
Conivaptan—Pain—Irbesartan—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Conivaptan—Constipation—Irbesartan—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Conivaptan—Insomnia—Losartan—type 2 diabetes mellitus	0.000212	0.00109	CcSEcCtD
Conivaptan—Nausea—Glyburide—type 2 diabetes mellitus	0.000209	0.00107	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000208	0.00107	CcSEcCtD
Conivaptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000205	0.00106	CcSEcCtD
Conivaptan—Pruritus—Valsartan—type 2 diabetes mellitus	0.000205	0.00105	CcSEcCtD
Conivaptan—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000205	0.00105	CcSEcCtD
Conivaptan—Confusional state—Ramipril—type 2 diabetes mellitus	0.000203	0.00104	CcSEcCtD
Conivaptan—Pruritus—Orlistat—type 2 diabetes mellitus	0.000203	0.00104	CcSEcCtD
Conivaptan—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000201	0.00103	CcSEcCtD
Conivaptan—Constipation—Losartan—type 2 diabetes mellitus	0.000201	0.00103	CcSEcCtD
Conivaptan—Pain—Losartan—type 2 diabetes mellitus	0.000201	0.00103	CcSEcCtD
Conivaptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000198	0.00102	CcSEcCtD
Conivaptan—Headache—Gliclazide—type 2 diabetes mellitus	0.000198	0.00102	CcSEcCtD
Conivaptan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000197	0.00101	CcSEcCtD
Conivaptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000197	0.00101	CcSEcCtD
Conivaptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000196	0.00101	CcSEcCtD
Conivaptan—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000195	0.001	CcSEcCtD
Conivaptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000193	0.000993	CcSEcCtD
Conivaptan—Hypotension—Ramipril—type 2 diabetes mellitus	0.000188	0.000966	CcSEcCtD
Conivaptan—Nausea—Gliclazide—type 2 diabetes mellitus	0.000187	0.000963	CcSEcCtD
Conivaptan—Pruritus—Metformin—type 2 diabetes mellitus	0.000187	0.00096	CcSEcCtD
Conivaptan—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000185	0.000953	CcSEcCtD
Conivaptan—Vomiting—Valsartan—type 2 diabetes mellitus	0.000184	0.000948	CcSEcCtD
Conivaptan—Vomiting—Orlistat—type 2 diabetes mellitus	0.000182	0.000936	CcSEcCtD
Conivaptan—Insomnia—Ramipril—type 2 diabetes mellitus	0.000182	0.000935	CcSEcCtD
Conivaptan—Headache—Valsartan—type 2 diabetes mellitus	0.000182	0.000934	CcSEcCtD
Conivaptan—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000181	0.000929	CcSEcCtD
Conivaptan—Headache—Orlistat—type 2 diabetes mellitus	0.000179	0.000922	CcSEcCtD
Conivaptan—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000176	0.000906	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000174	0.000892	CcSEcCtD
Conivaptan—Nausea—Valsartan—type 2 diabetes mellitus	0.000172	0.000885	CcSEcCtD
Conivaptan—Constipation—Ramipril—type 2 diabetes mellitus	0.000172	0.000884	CcSEcCtD
Conivaptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00017	0.000876	CcSEcCtD
Conivaptan—Nausea—Orlistat—type 2 diabetes mellitus	0.00017	0.000875	CcSEcCtD
Conivaptan—Vomiting—Metformin—type 2 diabetes mellitus	0.000168	0.000863	CcSEcCtD
Conivaptan—Pruritus—Losartan—type 2 diabetes mellitus	0.000166	0.000853	CcSEcCtD
Conivaptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000166	0.000852	CcSEcCtD
Conivaptan—Headache—Metformin—type 2 diabetes mellitus	0.000165	0.00085	CcSEcCtD
Conivaptan—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00016	0.000825	CcSEcCtD
Conivaptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000159	0.000817	CcSEcCtD
Conivaptan—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000158	0.000814	CcSEcCtD
Conivaptan—Nausea—Metformin—type 2 diabetes mellitus	0.000157	0.000806	CcSEcCtD
Conivaptan—Headache—Irbesartan—type 2 diabetes mellitus	0.000156	0.000802	CcSEcCtD
Conivaptan—Vomiting—Losartan—type 2 diabetes mellitus	0.000149	0.000766	CcSEcCtD
Conivaptan—Nausea—Irbesartan—type 2 diabetes mellitus	0.000148	0.000761	CcSEcCtD
Conivaptan—Headache—Losartan—type 2 diabetes mellitus	0.000147	0.000755	CcSEcCtD
Conivaptan—Pruritus—Ramipril—type 2 diabetes mellitus	0.000142	0.000731	CcSEcCtD
Conivaptan—Nausea—Losartan—type 2 diabetes mellitus	0.000139	0.000716	CcSEcCtD
Conivaptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000138	0.000707	CcSEcCtD
Conivaptan—Vomiting—Ramipril—type 2 diabetes mellitus	0.000128	0.000657	CcSEcCtD
Conivaptan—Headache—Ramipril—type 2 diabetes mellitus	0.000126	0.000647	CcSEcCtD
Conivaptan—Nausea—Ramipril—type 2 diabetes mellitus	0.000119	0.000614	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.71e-05	0.000544	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.65e-05	0.000539	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.6e-05	0.000535	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.5e-05	0.000527	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.45e-05	0.000523	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.44e-05	0.000522	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.42e-05	0.00052	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.37e-05	0.000516	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.34e-05	0.000514	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.3e-05	0.000511	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.3e-05	0.000511	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INSR—type 2 diabetes mellitus	6.27e-05	0.000508	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.26e-05	0.000508	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INSR—type 2 diabetes mellitus	6.22e-05	0.000504	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.17e-05	0.000501	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.16e-05	0.000499	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.15e-05	0.000499	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.13e-05	0.000497	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.12e-05	0.000496	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.11e-05	0.000496	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.1e-05	0.000495	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.08e-05	0.000493	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.04e-05	0.00049	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.99e-05	0.000486	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—C3—type 2 diabetes mellitus	5.9e-05	0.000478	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.86e-05	0.000475	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—C3—type 2 diabetes mellitus	5.86e-05	0.000475	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.82e-05	0.000472	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.7e-05	0.000463	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.69e-05	0.000461	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.69e-05	0.000461	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.66e-05	0.000459	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.65e-05	0.000458	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.65e-05	0.000458	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.61e-05	0.000455	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.57e-05	0.000451	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.54e-05	0.000449	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.51e-05	0.000447	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.51e-05	0.000447	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.5e-05	0.000446	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.47e-05	0.000444	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.47e-05	0.000444	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.42e-05	0.000439	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.39e-05	0.000437	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.39e-05	0.000437	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.38e-05	0.000436	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.36e-05	0.000434	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.36e-05	0.000434	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.33e-05	0.000432	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	5.3e-05	0.00043	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.29e-05	0.000429	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.18e-05	0.00042	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.14e-05	0.000417	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	5.14e-05	0.000417	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	5.07e-05	0.000411	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.02e-05	0.000407	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.99e-05	0.000405	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.98e-05	0.000404	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.96e-05	0.000402	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	4.93e-05	0.0004	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.93e-05	0.0004	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GCG—type 2 diabetes mellitus	4.9e-05	0.000397	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.9e-05	0.000397	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.85e-05	0.000394	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.84e-05	0.000392	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.82e-05	0.000391	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.8e-05	0.000389	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.62e-05	0.000374	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.58e-05	0.000372	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.54e-05	0.000368	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.53e-05	0.000367	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.5e-05	0.000365	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.5e-05	0.000365	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.29e-05	0.000348	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.26e-05	0.000346	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.25e-05	0.000345	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	4.24e-05	0.000344	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.22e-05	0.000342	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	4.19e-05	0.00034	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.19e-05	0.00034	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	4.19e-05	0.00034	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	4.18e-05	0.000339	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.18e-05	0.000339	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.16e-05	0.000338	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.16e-05	0.000338	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.16e-05	0.000337	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.15e-05	0.000336	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	4.14e-05	0.000335	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.13e-05	0.000335	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.12e-05	0.000334	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.09e-05	0.000331	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	4.05e-05	0.000329	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.04e-05	0.000327	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.03e-05	0.000326	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.01e-05	0.000325	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.99e-05	0.000324	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.96e-05	0.000321	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	3.87e-05	0.000314	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.84e-05	0.000312	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.79e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.76e-05	0.000305	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.63e-05	0.000295	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.61e-05	0.000292	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.57e-05	0.000289	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.54e-05	0.000287	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—C3—type 2 diabetes mellitus	3.49e-05	0.000283	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—C3—type 2 diabetes mellitus	3.46e-05	0.000281	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.32e-05	0.00027	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.32e-05	0.000269	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.31e-05	0.000269	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.3e-05	0.000268	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.29e-05	0.000267	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.29e-05	0.000267	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.26e-05	0.000264	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.24e-05	0.000263	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.24e-05	0.000263	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.23e-05	0.000262	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.22e-05	0.000261	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.22e-05	0.000261	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	3.21e-05	0.000261	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.21e-05	0.00026	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.18e-05	0.000258	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	3.17e-05	0.000257	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.06e-05	0.000248	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.04e-05	0.000246	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.89e-05	0.000235	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.87e-05	0.000233	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.77e-05	0.000225	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INS—type 2 diabetes mellitus	2.75e-05	0.000223	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.73e-05	0.000221	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.71e-05	0.00022	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.68e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.68e-05	0.000217	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.67e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.66e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.66e-05	0.000216	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.65e-05	0.000215	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.55e-05	0.000206	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.53e-05	0.000205	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.45e-05	0.000199	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.43e-05	0.000197	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.43e-05	0.000197	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.41e-05	0.000196	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.41e-05	0.000196	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.29e-05	0.000186	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.27e-05	0.000184	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	2.14e-05	0.000174	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	2.14e-05	0.000174	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.08e-05	0.000169	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.07e-05	0.000168	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.06e-05	0.000167	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.05e-05	0.000166	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.05e-05	0.000166	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.04e-05	0.000165	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	2.03e-05	0.000165	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	2.03e-05	0.000165	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.95e-05	0.000158	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.94e-05	0.000157	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.94e-05	0.000157	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.93e-05	0.000156	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.92e-05	0.000155	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.89e-05	0.000153	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.88e-05	0.000152	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.8e-05	0.000146	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.79e-05	0.000145	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.79e-05	0.000145	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.79e-05	0.000145	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.75e-05	0.000142	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.74e-05	0.000141	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.73e-05	0.00014	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.73e-05	0.00014	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.73e-05	0.00014	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.73e-05	0.00014	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.73e-05	0.00014	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.67e-05	0.000136	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.61e-05	0.00013	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.6e-05	0.000129	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.58e-05	0.000128	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.58e-05	0.000128	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.58e-05	0.000128	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.56e-05	0.000127	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.54e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.47e-05	0.000119	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.47e-05	0.000119	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.47e-05	0.000119	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.41e-05	0.000114	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.41e-05	0.000114	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.36e-05	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.36e-05	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.33e-05	0.000108	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.31e-05	0.000106	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.31e-05	0.000106	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.31e-05	0.000106	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.23e-05	9.98e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.21e-05	9.82e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.2e-05	9.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.15e-05	9.34e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.12e-05	9.06e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.11e-05	9.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.11e-05	9.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.11e-05	9.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.11e-05	9.02e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.11e-05	9e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.07e-05	8.65e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	9.92e-06	8.04e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	9.26e-06	7.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	9.07e-06	7.36e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	9.07e-06	7.36e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	8.9e-06	7.21e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	8.84e-06	7.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	8.84e-06	7.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	8.84e-06	7.17e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	8.79e-06	7.12e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	8.63e-06	7e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	8.53e-06	6.92e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	7.93e-06	6.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	7.93e-06	6.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	7.93e-06	6.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	7.78e-06	6.31e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.71e-06	6.25e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.55e-06	6.12e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	7.25e-06	5.88e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.17e-06	5.81e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.17e-06	5.81e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.87e-06	5.57e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.87e-06	5.57e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.93e-06	4.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.93e-06	4.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.9e-06	4.78e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.82e-06	4.72e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.65e-06	4.58e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.5e-06	4.46e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.39e-06	4.37e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.28e-06	4.28e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.26e-06	4.27e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.13e-06	4.16e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.06e-06	4.1e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.86e-06	3.94e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.77e-06	3.86e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.61e-06	3.74e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.54e-06	3.68e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.52e-06	3.67e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.47e-06	3.62e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.94e-06	3.19e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.86e-06	3.13e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.54e-06	2.87e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.39e-06	2.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.39e-06	2.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.1e-06	2.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.56e-06	1.26e-05	CbGpPWpGaD
